SEC Form 4 · accession 0001193125-26-296246
ALX ONCOLOGY HOLDINGS INC · ALXO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shelly Wong
Officer — SVP, FINANCE AND CAO
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001810182
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jul 1, 2026 | S | 1,404 | $2.04 | D | 88,401 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2026.